全文获取类型
收费全文 | 1930篇 |
免费 | 87篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 43篇 |
儿科学 | 60篇 |
妇产科学 | 58篇 |
基础医学 | 148篇 |
口腔科学 | 41篇 |
临床医学 | 183篇 |
内科学 | 467篇 |
皮肤病学 | 31篇 |
神经病学 | 120篇 |
特种医学 | 58篇 |
外国民族医学 | 4篇 |
外科学 | 355篇 |
综合类 | 32篇 |
一般理论 | 1篇 |
预防医学 | 64篇 |
眼科学 | 51篇 |
药学 | 138篇 |
中国医学 | 6篇 |
肿瘤学 | 178篇 |
出版年
2024年 | 3篇 |
2023年 | 24篇 |
2022年 | 54篇 |
2021年 | 98篇 |
2020年 | 57篇 |
2019年 | 73篇 |
2018年 | 73篇 |
2017年 | 46篇 |
2016年 | 52篇 |
2015年 | 52篇 |
2014年 | 90篇 |
2013年 | 127篇 |
2012年 | 150篇 |
2011年 | 182篇 |
2010年 | 107篇 |
2009年 | 72篇 |
2008年 | 135篇 |
2007年 | 117篇 |
2006年 | 91篇 |
2005年 | 80篇 |
2004年 | 79篇 |
2003年 | 55篇 |
2002年 | 53篇 |
2001年 | 23篇 |
2000年 | 19篇 |
1999年 | 16篇 |
1998年 | 9篇 |
1997年 | 7篇 |
1996年 | 5篇 |
1995年 | 5篇 |
1994年 | 6篇 |
1993年 | 3篇 |
1992年 | 10篇 |
1991年 | 8篇 |
1990年 | 12篇 |
1989年 | 2篇 |
1988年 | 3篇 |
1987年 | 2篇 |
1986年 | 3篇 |
1984年 | 2篇 |
1983年 | 6篇 |
1982年 | 2篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1976年 | 3篇 |
1974年 | 3篇 |
1971年 | 2篇 |
1969年 | 2篇 |
1964年 | 2篇 |
排序方式: 共有2038条查询结果,搜索用时 0 毫秒
21.
Yasser Emad Yasser Ragab Nashwa El-Shaarawy Johannes J. Rasker 《Clinical rheumatology》2012,31(11):1641-1647
Transient osteoporosis of the hip (TOH), also referred to as transient bone marrow edema syndrome, is most common in middle-aged men and often after trivial trauma or sport-related injuries. Diagnosis is usually made by eliminating other possible causes of hip pain. Magnetic resonance imaging (MRI) plays an important role in diagnosis and demonstrates a typical pattern of bone marrow edema (BME) in the form of diffuse low signal on T1-weighted images and high signal on T2 fat-suppressed or short T1 inversion recovery images. No consensus exists about the management of TOH, as it may progress to avascular necrosis. We describe eight cases of TOH treated with alendronate resulting in improvement of pain and function and complete resolution of BME on MRI. The literature is reviewed regarding TOH and the relationship with bone marrow edema syndrome, avascular necrosis of the hip, and regional migratory osteoporosis. To our knowledge, this is the first report describing the improvement of this condition after of alendronate with documented radiological improvement on follow-up MRI. 相似文献
22.
23.
24.
Aim
To compare the value of Procalcitonin (PCT) as a marker of surgical site infection to other inflammatory markers, including C-Reactive Protein (CRP), White Cell Count (WCC) and Erythrocyte Sedimentation Rate (ESR) in patients undergoing a number of spinal procedures. This study also aims to describe the biokinetic profile of the above-named markers in patients developing surgical site infection and those remaining infection-free post-operatively.Methods
200 patients undergoing four routine elective spinal procedures were included for analysis. All patients had blood specimens taken at baseline, day 1, 2, 3, 4 and 5 post-operatively for analysis of PCT, CRP, ESR and WCC levels. All patients were monitored for early surgical site infection. Patients with other sources of infection in the early postoperative period were excluded.Results
Procalcitonin was the most sensitive and specific marker for the detection of surgical site infection in the immediate post-operative period with sensitivity and specificity of 100% and 95.2% respectively. Although Procalcitonin is an inflammatory marker, extent of surgical physiological insult did not alter its biokinetics as opposed to the other inflammatory markers making it a valuable marker of infection.Conclusion
Procalcitonin was found to be superior to the other inflammatory markers investigated in this study as a marker for early surgical site infection in patients undergoing spinal surgery. 相似文献25.
Bassel El Zorkany Nizar Al Ani Samar Al Emadi Jamal Al Saleh Imad Uthman Yasser El Dershaby Mohamed Mounir Hani Al Moallim 《Clinical rheumatology》2018,37(5):1143-1152
The increasing availability of biosimilar medicines in Middle Eastern regions may provide an opportunity to increase the number of rheumatology patients who have access to traditionally more expensive biologic medicines. However, as well as a lack of real-world data on the use of biosimilar medicines in practice, the availability of intended copies in the region may undermine physician confidence in prescribing legitimate biosimilar medicines. There is a need for regional recommendations for healthcare professionals to ensure that biosimilar drugs can be used safely. Therefore, a literature search was performed with the aim of providing important recommendations for the regulation and use of biosimilar medicines in the Middle East from key opinion leaders in rheumatology from the region. These recommendations focus on improving the availability of relevant real-world data, ensuring that physicians are aware of the difference between intended copies and true biosimilars and ensuring that physicians are responsible for making any prescribing and switching decisions. 相似文献
26.
27.
Leila R. Martins Yasser Perera Paulo Lúcio Maria G. Silva Silvio E. Perea Jo?o T. Barata 《Oncotarget》2014,5(1):258-263
Chronic lymphocytic leukemia (CLL) remains an incurable malignancy, urging for the identifcation of new molecular targets for therapeutic intervention. CLL cells rely on overexpression and hyperactivation of the ubiquitous serine/threonine protein kinase CK2 for their viability in vitro. CIGB-300 is a cell-permeable selective CK2 inhibitor peptide undergoing clinical trials for several cancers. Here, we show that CIGB-300 promotes activation of the tumor suppressor PTEN and abrogates PI3K-mediated downstream signaling in CLL cells. In accordance, CIGB-300 decreases the viability and proliferation of CLL cell lines, promotes apoptosis of primary leukemia cells and displays antitumor efcacy in a xenograft mouse model of human CLL. Our studies provide pre-clinical support for the testing and possible inclusion of CK2 inhibitors in the clinical arsenal against CLL. 相似文献
28.
Steven Kaptik Yasser Jamal Barbara Kay Jackson Claudio Tombazzi 《The American journal of the medical sciences》2010,339(1):95-97
Chronic mesenteric ischemia classically presents as “intestinal angina” with generalized postprandial abdominal pain lasting up to 3 hours. Over time, these episodes can become much more intense and ultimately lead to sitophobia with significant weight loss. Symptoms are not specific and often mistakenly attributed to other gastrointestinal etiologies such as peptic ulcer disease. Gastric ulcerations as a direct result of mesenteric ischemia have been reported but are relatively rare because of the rich collateral blood supply to the stomach. Therefore, a diagnosis of ischemic gastropathy is seldom entertained in patients presenting with abdominal pain and gastriculcers. 相似文献
29.
Yasser Mostafa Hafez Omnia Safwat El-Deeb Marwa Mohamed Atef 《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2018,12(6):1065-1070
Background
Diabetic foot ulceration (DFU) is a serious diabetic complication that can progress to amputation and since SIRT1 regulates glucose metabolism, inflammation, and oxidative stress which are the major contributors in diabetic complications, So we aimed to discuss its role as an epigenetic biomarker in DFU and highlight its link to oxidative stress and inflammatory cytokines.Method
60 DM patients were enrolled in the study, 30 without DFU and 30 with DFU in addition to 15 healthy subjects (control group). SIRT1 mRNA relative gene expression was assessed. Catalase activity, advanced glycation end products (AGEs), tumor necrosis factor alpha (TNFα), interleukin 6 (IL-6) and High mobility group box1 (HMGB1) levels were measured. DNA fragmentation was also performed.Result
SIRT1 expression and catalase activity were significantly decreased in diabetic patients compared to control group with the lowest levels in DFU patients, TNFα, IL-6, HMGB 1 and AGEs levels were significantly higher in the diabetic patients compared to control group with the highest levels in DFU patients. DNA fragmentation was more profound in DFU patients.Conclusion
The study revealed that SIRT1 mRNA expression can be considered as a novel biomarker in DFU being a major player involved in its pathogenesis. 相似文献30.
The role of IGF-I and its binding proteins in the development of type 2 diabetes and cardiovascular disease 总被引:2,自引:0,他引:2
Patients with insulin resistance and type 2 diabetes have an excessive risk of cardiovascular disease (CVD); this increased risk is not fully explained by traditional risk factors such as hypertension and dyslipidaemias. There is now compelling evidence to suggest that abnormalities of insulin-like growth factor-I (IGF-I) and one of its binding proteins, insulin-like growth factor-binding protein-1 (IGFBP-1), occur in insulin-resistant states and may be significant factors in the pathophysiology of CVD. We reviewed articles and relevant bibliographies following a systematic search of MEDLINE for English language articles between 1966 and the present, using an initial search strategy combining the MeSH terms: IGF, diabetes and CVD. Our aim was first to review the role of IGF-I in vascular homeostasis and to explore the mechanisms by which it may exert its effects. We also present an overview of the physiology of the IGF-binding proteins, and finally, we sought to summarize the evidence to date describing the changes in the insulin/IGF-I/IGFBP-1 axis that occur in type 2 diabetes and CVD; in particular, we have focused on the potential vasculoprotective effects of both IGF-I and IGFBP-1. We conclude that this system represents an interesting and novel therapeutic target in the prevention of CVD in type 2 diabetes. 相似文献